您当前的位置: 首页 > 数据库
  • 全部(1880)
  • 腹部手术(323)
  • 胸科手术(41)
  • 血管手术(5)
  • 心脏手术(56)
  • 神经外科(4)
  • 头颈部(35)
  • 骨科(78)
  • 泌尿外科(0)
  • 妇产手术(56)
  • 日间手术(26)
  • 手术室外(0)
  • 创伤和烧伤(0)
  • 非心脏手术(410)
  • 老年(0)
  • 小儿新生儿(126)
  • 特殊患者(42)
  • 未说明手术类型(678)
  • 术前宣教(21)
  • 术前评估(33)
  • 术前用药(15)
  • 术前禁食水(12)
  • 麻醉选择(21)
  • 麻醉用药(10)
  • 术中监测(23)
  • 液体管理(14)
  • 血液保护(3)
  • 体温管理(8)
  • 术后疼痛(43)
  • POD(8)
  • PONV(10)
  • 术后康复(50)
  • 特殊情况(43)
  • 术前肠道准备(9)
Array ( [id] => 2174 [catid] => 311 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2174.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Application of meticulous haemostasis should be considered a routine procedure.(Evidence: Level B,Recommendation: Class IIa) [laiyuan] => 应用细致的止血术应视为常规程序。(证据级别:B;推荐强度:IIa) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
应用细致的止血术应视为常规程序。(证据级别:B;推荐强度:IIa)

Application of meticulous haemostasis should be considered a routine procedure.(Evidence: Level B,Recommendation: Class IIa)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2175 [catid] => 311 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2175.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => A feedback/monitoring programme or clinical decision support system should be considered to be assessed before blood transfusion.(Evidence: Level B,Recommendation: Class IIa) [laiyuan] => 在输血前,应考虑采用反馈/监测程序或临床决策支持系统进行评估。(证据级别:B;推荐强度:IIa) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
在输血前,应考虑采用反馈/监测程序或临床决策支持系统进行评估。(证据级别:B;推荐强度:IIa)

A feedback/monitoring programme or clinical decision support system should be considered to be assessed before blood transfusion.(Evidence: Level B,Recommendation: Class IIa)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2176 [catid] => 311 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2176.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Before allogenic blood transfusion, it should be considered to obtain an extensive consent about risks asssociated with transfusion.(Evidence: Level C,Recommendation: Class IIa) [laiyuan] => 异体输血前应对输血相关风险获得一致同意。(证据级别:C;推荐强度:IIa) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
异体输血前应对输血相关风险获得一致同意。(证据级别:C;推荐强度:IIa)

Before allogenic blood transfusion, it should be considered to obtain an extensive consent about risks asssociated with transfusion.(Evidence: Level C,Recommendation: Class IIa)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2177 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2177.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => If PCI is indicated before NCS, the use of new-generation DES is recommended over BMS and balloon angioplasty(Evidence: Level A ,Recommendation: Class I) [laiyuan] => CCS患者NCS之前如有PCI指征,建议使用新一代DES,而非BMS或球囊扩张。(证据级别:A;推荐强度:I) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
CCS患者NCS之前如有PCI指征,建议使用新一代DES,而非BMS或球囊扩张。(证据级别:A;推荐强度:I)

If PCI is indicated before NCS, the use of new-generation DES is recommended over BMS and balloon angioplasty(Evidence: Level A ,Recommendation: Class I)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2178 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2178.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Pre-operative evaluation of patients with an indication for PCI by an expert team (surgeon and cardiologist) should be considered before elective NCS.(Evidence: Level C,Recommendation: Class IIa) [laiyuan] => CCS患者择期NCS前的PCI指证评估需包括外科医师和心内科医师。(证据级别:C;推荐强度:IIa) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
CCS患者择期NCS前的PCI指证评估需包括外科医师和心内科医师。(证据级别:C;推荐强度:IIa)

Pre-operative evaluation of patients with an indication for PCI by an expert team (surgeon and cardiologist) should be considered before elective NCS.(Evidence: Level C,Recommendation: Class IIa)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2179 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2179.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Myocardial revascularization before high-risk elective NCS may be considered, depending on the amount of ischaemic myocardium, refractory symptoms, and findings at coronary angiography (as in the case of left main disease).(Evidence: Level B,Recommendation: Class IIb ) [laiyuan] => 对于高风险择期CCS患者,可考虑NCS前行心肌血运重建,取决于缺血心肌数量、症状顽固程度、冠脉造影结果。(证据级别:B;推荐强度:IIb) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
对于高风险择期CCS患者,可考虑NCS前行心肌血运重建,取决于缺血心肌数量、症状顽固程度、冠脉造影结果。(证据级别:B;推荐强度:IIb)

Myocardial revascularization before high-risk elective NCS may be considered, depending on the amount of ischaemic myocardium, refractory symptoms, and findings at coronary angiography (as in the case of left main disease).(Evidence: Level B,Recommendation: Class IIb )

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2180 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2180.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => Routine myocardial revascularization before lowand intermediate-risk NCS in patients with CCS is not recommended.(Evidence: Level B,Recommendation: Class III) [laiyuan] => CCS患者拟行低、中风险的NCS,不建议常规行术前心肌血运重建。(证据级别:B;推荐强度:III) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
CCS患者拟行低、中风险的NCS,不建议常规行术前心肌血运重建。(证据级别:B;推荐强度:III)

Routine myocardial revascularization before lowand intermediate-risk NCS in patients with CCS is not recommended.(Evidence: Level B,Recommendation: Class III)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2181 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2181.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => If NCS can safely be postponed (e.g. at least 3 months), it is recommended that patients with ACS being scheduled for NCS undergo diagnostic and therapeutic interventions as recommended for ACS patients in general.(Evidence: Level A ,Recommendation: Class I) [laiyuan] => 合并 ACS 的患者拟行NCS,建议推迟 NCS(如至少3个月),先按ACS 处理一般原则实施CAD 的诊断、治疗和干预。(证据级别:A;推荐强度:I) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
合并 ACS 的患者拟行NCS,建议推迟 NCS(如至少3个月),先按ACS 处理一般原则实施CAD 的诊断、治疗和干预。(证据级别:A;推荐强度:I)

If NCS can safely be postponed (e.g. at least 3 months), it is recommended that patients with ACS being scheduled for NCS undergo diagnostic and therapeutic interventions as recommended for ACS patients in general.(Evidence: Level A ,Recommendation: Class I)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2182 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2182.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In the unlikely combination of a life-threatening clinical condition requiring urgent NCS, and NSTE-ACS with an indication for revascularization, the priorities for surgery on a case-by-case basis should be considered by the expert team.(Evidence: Level C,Recommendation: Class IIa) [laiyuan] => 一旦遇到合并有冠脉血运重建指证的 NSTE-ACS患者需行紧急NCS,应由专家团队基于具体情况 共同商议手术的优先顺序。(证据级别:C;推荐强度:IIa) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
一旦遇到合并有冠脉血运重建指证的 NSTE-ACS患者需行紧急NCS,应由专家团队基于具体情况 共同商议手术的优先顺序。(证据级别:C;推荐强度:IIa)

In the unlikely combination of a life-threatening clinical condition requiring urgent NCS, and NSTE-ACS with an indication for revascularization, the priorities for surgery on a case-by-case basis should be considered by the expert team.(Evidence: Level C,Recommendation: Class IIa)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读
Array ( [id] => 2183 [catid] => 313 [title] => 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery [thumb] => [keywords] => [description] => [hits] => [uid] => 3 [author] => 甘肃中医院 [status] => 9 [url] => https://www.anes-guide.com/show/2183.html [link_id] => 0 [tableid] => 0 [inputip] => 14.105.95.116 [inputtime] => 2024-12-19 09:42:42 [updatetime] => 2024-12-19 09:42:42 [displayorder] => 0 [nrjc] => Array ( ) [nrsh] => Array ( ) [xzl] => 0 [dzl] => 0 [wailian] => https://pubmed.ncbi.nlm.nih.gov/36017553/ [demo_url] => [zjpjff] => LOE [zjfj] => [tjqd] => [nianfen] => 2022 [guojia] => the European Society of Anaesthesiology and Intens [pdf] => [tjyjyw] => [lyyw] => In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B,Recommendation: Class I) [laiyuan] => 疑似/确诊 HF 患者拟行高风险 NCS 前,建议 UCG 检查评估左室功能、并测定 NTproBNP/BNP水平(除非近期曾检查过)。(证据级别:B;推荐强度:I) [znzldj] => A [_inputtime] => 1734572562 [_updatetime] => 1734572562 [_nrjc] => [_nrsh] => )
推荐意见
疑似/确诊 HF 患者拟行高风险 NCS 前,建议 UCG 检查评估左室功能、并测定 NTproBNP/BNP水平(除非近期曾检查过)。(证据级别:B;推荐强度:I)

In patients with suspected or known HF scheduled for high-risk NCS, it is recommended to evaluate LV function with echocardiography and measurement of NT-proBNP/BNP levels, unless this has recently been performed.(Evidence: Level B,Recommendation: Class I)

证据评价方法:LOE

指南质量等级:A

年份:2022

国家:the European Society of Anaesthesiology and Intens

阅读